News
KBLB
0.115
-10.07%
-0.013
Financial Report Articles: Overview and Analysis
Press release · 17h ago
Weekly Report: what happened at KBLB last week (0506-0510)?
Weekly Report · 2d ago
Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations
Barchart · 6d ago
Weekly Report: what happened at KBLB last week (0429-0503)?
Weekly Report · 05/06 10:14
KRAIG BIOCRAFT LABORATORIES REPORTS SIGNING LANDMARK AGREEMENTS IN SOUTH EAST ASIA
Reuters · 04/29 11:05
Weekly Report: what happened at KBLB last week (0422-0426)?
Weekly Report · 04/29 10:17
Weekly Report: what happened at KBLB last week (0415-0419)?
Weekly Report · 04/22 10:12
Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials
Kraig Biocraft Laboratories, Inc. Has completed rearing of the first generation of its new BAM-1 parental strains. Kraig Labs has successfully produced cocoon at rates that exceeded all expectations and control parameters in its spring production trial. The Company has reached a major milestone.
Barchart · 04/22 06:05
Kraig Biocraft launches spring production trials in Southeast Asia for spider silk
Consumer Kraig Biocraft launches spring production trials in Southeast Asia for spider silk. Spring production trials for the new BAM-1 hybrid have begun and are well on track to meet the company's expectations and timeline for the silkworm hybrid. The company's CEO remains in Asia to oversee the trials.
Seeking Alpha · 04/15 11:33
Weekly Report: what happened at KBLB last week (0408-0412)?
Weekly Report · 04/15 10:07
Kraig Biocraft Laboratories Announces Successful Launch of Spring Production Trials in Southeast Asia for Spider Silk
Spring production trials for the new BAM-1 hybrid have begun and are well on track to meet the Company's expectations and timeline. Kraig Biocraft Laboratories, Inc. Is a biotechnology company. The company's spring production trials of the new hybrid are expected to begin in April.
Barchart · 04/15 06:05
Kraig Biocraft Laboratories signs agreement with Vietnam Sericulture Association
Kraig Biocraft Laboratories signs agreement with Vietnam Sericulture Association. Under the agreement, the VSA will assist the firm in obtaining formal intellectual property registration of its BAM-1 hybrid silkworm strain in Vietnam. The company disclosed its production plans to the company.
Seeking Alpha · 04/08 11:16
KRAIG BIOCRAFT LABORATORIES SIGNS LANDMARK AGREEMENT IN VIETNAM'S SILK PRODUCTION CAPITAL
Reuters · 04/08 11:05
Weekly Report: what happened at KBLB last week (0401-0405)?
Weekly Report · 04/08 10:10
Weekly Report: what happened at KBLB last week (0325-0329)?
Weekly Report · 04/01 10:09
Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics
Barchart · 03/28 06:05
Weekly Report: what happened at KBLB last week (0318-0322)?
Weekly Report · 03/25 10:11
Kraig Biocraft Laboratories Brings Leading Sericulture Expert from India for Launch of Spring Production Trials
Dr. Nirmal Kumar will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid. Dr. Kumar is a globally recognized expert in sericulture. Kraig Biocraft Laboratories, Inc.
Barchart · 03/19 06:05
Weekly Report: what happened at KBLB last week (0311-0315)?
Weekly Report · 03/18 10:10
Kraig Biocraft Laboratories Senior Management travels to Vietnam for Launch of Spring Trials
Senior management members will travel to Vietnam this week to oversee the launch of the spring production trials and lay the groundwork for the Company's planned commercial expansion. Kraig Biocraft Laboratories, Inc. Is a leading manufacturer of biocrafts. The company is based in Michigan.
Barchart · 03/12 06:05
More
Webull provides a variety of real-time KBLB stock news. You can receive the latest news about Kraig Biocraft Laboratories In through multiple platforms. This information may help you make smarter investment decisions.
About KBLB
Kraig Biocraft Laboratories, Inc. is a biotechnology company focused on the development and commercialization of spider silks. The Company's lead product is a genetically engineered spider silk known as Monster Silk. Monster Silk is a composite fiber, which is spun by its line of transgenic silkworms. Monster Silk is composed of a combination of both spider silk proteins and silk from a silkworm. The Company uses genetic engineering technologies to develop fibers for use in target markets, including the textile, specialty fiber and technical textile industries. Specialty fibers are engineered for specific uses that require strength, flexibility, heat resistance and/or chemical resistance. The technical textile industry involves products for both industrial and consumer products, such as filtration fabrics, medical textiles (such as sutures and artificial ligaments), safety and protective clothing, and fabrics used in military and aerospace applications.